FindTrial
Sign In

prospective study of minimal residual disease-directed donor lymphocyte infusion

minimal residual disease-directed donor lymphocyte infusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002252
Enrollment
Unknown
Registered
2012-06-08
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukemia

Interventions

trial group:DLI

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. leukemia patients with positive MRD after HSCT; 2. without severe infection, without organ failure.

Exclusion criteria

Exclusion criteria: 1·uncontrolled infection; 2. organ failure; 3. hematologic relapse .

Design outcomes

Primary

MeasureTime frame
relapse rate;—

Countries

China

Contacts

Public ContactHuang Xiaojun
huangxiaojun@bjmu.edu.cn+86 10 88326006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026